• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与Nanostim无导线起搏器植入相关的学习曲线。

The learning curve associated with the implantation of the Nanostim leadless pacemaker.

作者信息

Tjong Fleur V Y, Beurskens Niek E G, Neuzil Petr, Defaye Pascal, Delnoy Peter-Paul, Ip John, Guerrero Juan Jose Garcia, Rashtian Mayer, Banker Rajesh, Reddy Vivek, Exner Derek, Sperzel Johannes, Knops Reinoud E

机构信息

Department of Clinical and Experimental Cardiology, Amsterdam UMC, location AMC, University of Amsterdam, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands.

Na Homolce Hospital, Praha, Czech Republic.

出版信息

J Interv Card Electrophysiol. 2018 Nov;53(2):239-247. doi: 10.1007/s10840-018-0438-8. Epub 2018 Aug 13.

DOI:10.1007/s10840-018-0438-8
PMID:30105428
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6182715/
Abstract

PURPOSE

Use of novel medical technologies, such as leadless pacemaker (LP) therapy, may be subjected to a learning curve effect. The objective of the current study was to assess the impact of operators' experience on the occurrence of serious adverse device effects (SADE) and procedural efficiency.

METHODS

Patients implanted with a Nanostim LP (Abbott, USA) within two prospective studies (i.e., LEADLESS ll IDE and Leadless Observational Study) were assessed. Patients were categorized into quartiles based on operator experience. Learning curve analysis included the comparison of SADE rates at 30 days post-implant per quartile and between patients in quartile 4 (> 10 implants) and patients in quartiles 1 through 3 (1-10 implants). Procedural efficiency was assessed based on procedure duration and repositioning attempts.

RESULTS

Nanostim LP implant was performed in 1439 patients by 171 implanters at 60 centers in 10 countries. A total of 91 (6.4%) patients experienced a SADE in the first 30 days. SADE rates dropped from 7.4 to 4.5% (p = 0.038) after more than 10 implants per operator. Total procedure duration decreased from 30.9 ± 19.1 min in quartile 1 to 21.6 ± 13.2 min (p < 0.001) in quartile 4. The need for multiple repositionings during the LP procedure reduced in quartile 4 (14.8%), compared to quartiles 1 (26.8%; p < 0.001), 2 (26.6%; p < 0.001), and 3 (20.4%; p = 0.03).

CONCLUSIONS

Learning curves exist for Nanostim LP implantation. Procedure efficiency improved with increased operator experience, according to a decrease in the incidence of SADE, procedure duration, and repositioning attempts.

摘要

目的

使用新型医疗技术,如无导线起搏器(LP)治疗,可能会受到学习曲线效应的影响。本研究的目的是评估操作者经验对严重不良器械效应(SADE)发生情况和手术效率的影响。

方法

对两项前瞻性研究(即无导线II期器械临床试验和无导线观察性研究)中植入Nanostim LP(美国雅培公司)的患者进行评估。根据操作者经验将患者分为四分位数。学习曲线分析包括比较各四分位数植入后30天的SADE发生率,以及比较第四四分位数(>10例植入)患者与第一至第三四分位数(1-10例植入)患者之间的SADE发生率。根据手术时间和重新定位尝试次数评估手术效率。

结果

171名植入者在10个国家的60个中心为1439名患者植入了Nanostim LP。共有91名(6.4%)患者在植入后的前30天内出现了SADE。每位操作者植入超过10例后,SADE发生率从7.4%降至4.5%(p = 0.038)。总手术时间从第一四分位数的30.9±19.1分钟降至第四四分位数的21.6±13.2分钟(p < 0.001)。与第一四分位数(26.8%;p < 0.001)、第二四分位数(26.6%;p < 0.001)和第三四分位数(20.4%;p = 0.03)相比,第四四分位数在LP手术期间需要多次重新定位的情况有所减少(14.8%)。

结论

Nanostim LP植入存在学习曲线。随着操作者经验的增加,手术效率得到提高,SADE发生率、手术时间和重新定位尝试次数均有所降低。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/55a9/6182715/f32055f18b69/10840_2018_438_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/55a9/6182715/fe6430940735/10840_2018_438_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/55a9/6182715/fc38115203d8/10840_2018_438_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/55a9/6182715/6d202d4e3a2e/10840_2018_438_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/55a9/6182715/f32055f18b69/10840_2018_438_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/55a9/6182715/fe6430940735/10840_2018_438_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/55a9/6182715/fc38115203d8/10840_2018_438_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/55a9/6182715/6d202d4e3a2e/10840_2018_438_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/55a9/6182715/f32055f18b69/10840_2018_438_Fig4_HTML.jpg

相似文献

1
The learning curve associated with the implantation of the Nanostim leadless pacemaker.与Nanostim无导线起搏器植入相关的学习曲线。
J Interv Card Electrophysiol. 2018 Nov;53(2):239-247. doi: 10.1007/s10840-018-0438-8. Epub 2018 Aug 13.
2
Comparison of the safety and efficacy of Nanostim and Micra transcatheter leadless pacemaker (LP) extractions: a multicenter experience.比较 Nanostim 和 Micra 经导管无导线起搏器(LP)取出的安全性和疗效:一项多中心经验。
J Interv Card Electrophysiol. 2020 Jan;57(1):133-140. doi: 10.1007/s10840-019-00684-y. Epub 2020 Jan 6.
3
Impact of operator experience and training strategy on procedural outcomes with leadless pacing: Insights from the Micra Transcatheter Pacing Study.术者经验和培训策略对无导线起搏手术结果的影响:来自Micra经导管起搏研究的见解
Pacing Clin Electrophysiol. 2017 Jul;40(7):834-842. doi: 10.1111/pace.13094. Epub 2017 Jun 16.
4
Nanostim leadless pacemaker retrieval and simultaneous micra leadless pacemaker replacement: a single-center experience.纳米无导线起搏器取出术和同期微毫无导线起搏器更换术:单中心经验。
J Interv Card Electrophysiol. 2020 Jan;57(1):125-131. doi: 10.1007/s10840-019-00647-3. Epub 2019 Nov 14.
5
Midterm Safety and Performance of a Leadless Cardiac Pacemaker: 3-Year Follow-up to the LEADLESS Trial (Nanostim Safety and Performance Trial for a Leadless Cardiac Pacemaker System).无导线心脏起搏器的中期安全性和性能:LEADLESS试验(无导线心脏起搏器系统的Nanostim安全性和性能试验)的3年随访
Circulation. 2018 Feb 6;137(6):633-635. doi: 10.1161/CIRCULATIONAHA.117.030106.
6
Combined leadless pacemaker and subcutaneous implantable defibrillator therapy: feasibility, safety, and performance.无导线起搏器与皮下植入式除颤器联合治疗:可行性、安全性及性能
Europace. 2016 Nov;18(11):1740-1747. doi: 10.1093/europace/euv457. Epub 2016 Mar 3.
7
Comparative study of acute and mid-term complications with leadless and transvenous cardiac pacemakers.无导线与经静脉心脏起搏器的急性与中期并发症比较研究。
Heart Rhythm. 2018 Jul;15(7):1023-1030. doi: 10.1016/j.hrthm.2018.04.022.
8
A worldwide experience of the management of battery failures and chronic device retrieval of the Nanostim leadless pacemaker.全球范围内对 Nanostim 无导线起搏器电池故障和慢性设备取出管理的经验。
Heart Rhythm. 2017 Dec;14(12):1756-1763. doi: 10.1016/j.hrthm.2017.07.004. Epub 2017 Jul 10.
9
Leadless pacemaker implantation after explantation of infected conventional pacemaker systems: A viable solution?感染性传统起搏器系统取出后植入无导线起搏器:可行的解决方案?
Heart Rhythm. 2019 Jan;16(1):66-71. doi: 10.1016/j.hrthm.2018.07.006. Epub 2018 Jul 6.
10
Primary safety results from the LEADLESS Observational Study.无导线心脏起搏器 LEADLESS 观察研究的主要安全性结果。
Europace. 2018 Sep 1;20(9):1491-1497. doi: 10.1093/europace/eux359.

引用本文的文献

1
Comparison of Safety of Leadless Pacemakers and Transvenous Pacemakers: A Meta-Analysis.无导线起搏器与经静脉起搏器安全性的比较:一项荟萃分析。
Cureus. 2023 Sep 12;15(9):e45086. doi: 10.7759/cureus.45086. eCollection 2023 Sep.
2
Leadless pacemaker perforations: Clinical consequences and related device and user problems.无导线起搏器穿孔:临床后果及相关器械和使用者问题。
J Cardiovasc Electrophysiol. 2022 Feb;33(2):154-159. doi: 10.1111/jce.15343. Epub 2022 Jan 7.

本文引用的文献

1
Impact of operator experience and training strategy on procedural outcomes with leadless pacing: Insights from the Micra Transcatheter Pacing Study.术者经验和培训策略对无导线起搏手术结果的影响:来自Micra经导管起搏研究的见解
Pacing Clin Electrophysiol. 2017 Jul;40(7):834-842. doi: 10.1111/pace.13094. Epub 2017 Jun 16.
2
Permanent Leadless Cardiac Pacemaker Therapy: A Comprehensive Review.无导线心脏起搏器永久治疗:全面综述。
Circulation. 2017 Apr 11;135(15):1458-1470. doi: 10.1161/CIRCULATIONAHA.116.025037.
3
A Leadless Intracardiac Transcatheter Pacing System.
无导线心脏内介入起搏系统。
N Engl J Med. 2016 Feb 11;374(6):533-41. doi: 10.1056/NEJMoa1511643. Epub 2015 Nov 9.
4
Learning curves for transfemoral transcatheter aortic valve replacement in the PARTNER-I trial: Success and safety.PARTNER-I试验中经股动脉经导管主动脉瓣置换术的学习曲线:成功率与安全性。
Catheter Cardiovasc Interv. 2016 Jan 1;87(1):165-75. doi: 10.1002/ccd.26121. Epub 2015 Oct 1.
5
The learning curve associated with the introduction of the subcutaneous implantable defibrillator.与皮下植入式除颤器引入相关的学习曲线。
Europace. 2016 Jul;18(7):1010-5. doi: 10.1093/europace/euv299. Epub 2015 Aug 31.
6
Percutaneous Implantation of an Entirely Intracardiac Leadless Pacemaker.经皮植入全心腔内无导线起搏器。
N Engl J Med. 2015 Sep 17;373(12):1125-35. doi: 10.1056/NEJMoa1507192. Epub 2015 Aug 30.
7
Learning curves for transfemoral transcatheter aortic valve replacement in the PARTNER-I trial: Technical performance.PARTNER-I试验中经股动脉经导管主动脉瓣置换术的学习曲线:技术性能
Catheter Cardiovasc Interv. 2016 Jan 1;87(1):154-62. doi: 10.1002/ccd.26120. Epub 2015 Aug 10.
8
Permanent leadless cardiac pacing: results of the LEADLESS trial.无导线心脏起搏的永久性:LEADLESS 试验结果。
Circulation. 2014 Apr 8;129(14):1466-71. doi: 10.1161/CIRCULATIONAHA.113.006987. Epub 2014 Mar 24.
9
Safety of transvenous cardiac resynchronization system implantation in patients with chronic heart failure: combined results of over 2,000 patients from a multicenter study program.慢性心力衰竭患者经静脉植入心脏再同步化系统的安全性:一项多中心研究项目中2000多名患者的综合结果
J Am Coll Cardiol. 2005 Dec 20;46(12):2348-56. doi: 10.1016/j.jacc.2005.08.031.
10
Incidence and predictors of cardiac perforation after permanent pacemaker placement.永久性起搏器植入术后心脏穿孔的发生率及预测因素
Heart Rhythm. 2005 Sep;2(9):907-11. doi: 10.1016/j.hrthm.2005.06.011.